Alternative Bio Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Alternative Bio Inc. - overview
Location
-, -, Singapore
Primary Industry
Biotechnology
About
Based in Singapore, Alternative Bio Inc. provides novel therapeutics. The company was co-founded by Fei Lan, Yang Shi, and Or Gozani. In December 2022, Alternative Bio raised USD 15 million in Seed funding co-led by investors Eight Roads Ventures and F-Prime Capital with participation from another investor Sequoia Capital.
The company develops novel therapeutics that focus mainly on the untapped class of post-translational modifying enzymes. The company plans to use the December 2022 funding to leverage its discovery platform and advance the lead drug candidates to treat some of the most intractable cancers.
Current Investors
Hong Shan, Eight Roads Ventures, F-Prime Capital
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.